Pharmaceutical remedy "Rutatsid." Instructions for use

Pharmacological agent "Rutatsid" (instructions for use contains this information) is available in the form of chewable tablets. Each contains five hundred milligrams of hydrotalcite, the active active ingredient. Additional substances - sodium saccharin, sodium starch glycollate, magnesium stearate, talc and spike mint (flavor). Tablets have a mild pepper smell, white (or almost white) color and beveled edges.

The drug "Rutatsid", the instruction for use informs, refers to the pharmacotherapeutic group of antacids.

The structure of the main active component - hydrotalcite - layered-mesh. The content of magnesium and aluminum in it is low, their release is carried out gradually and depends on the level of acidity of the gastric juice. As a result of the drug, active and prolonged neutralization of hydrochloric acid is maintained and the pH is maintained at a level close to normal. In addition, this drug reduces the proteolytic effects of pepsin and binds bile acids.

The drug "Rutatsid", the instruction for use indicates, is adsorbed in the small intestine. Immediately after its administration in the human body (in its blood), the content of aluminum and magnesium ions is temporarily increased. However, they do not penetrate into bone and nerve tissues (under the condition of normal functioning of the kidneys, which are responsible for the withdrawal of the drug).

Indications for the use of this medication is the presence of the following diseases:

• Reflux-esophagitis;
• Ulcerative lesions of the stomach and duodenum;
• Acute or chronic gastritis, which is in the acute stage;
• Sour eructation after violations of diet, alcohol abuse, medication intake;
• Heartburn, pain and discomfort in the epigastric region.

The drug "Rutatsid", the instruction for use confirms, is contraindicated in the presence of renal insufficiency, hypersensitivity to the active ingredient, and also if the patient's age is less than six years.

There is no confirmed data on the negative impact of the medication during the period of bearing or breastfeeding. Therefore, taking the drug "Rutatsid" during pregnancy can be done only after consulting a specialist. Information on the ability to penetrate the medication into breast milk is not available.

Drug "Rutatsid". Instructions for use

Acceptable tablets should be thoroughly chewed. Use them should be one to two pieces up to four times a day 1 hour after eating and before going to bed.

If you need a one-time reception (for complaints about discomfort after a violation of diet, for example) take one or two tablets once.

Patients between the ages of six and twelve are prescribed half of the above dose.

There were no facts of overdose by the pharmaceutical agent under consideration. In the case of a significant excess of the recommended amount of the drug should be monitored on the functioning of the kidneys.

The drug "Rutatsid", instructions for use informs, can cause diarrhea.

It is noted that this drug reduces the level of absorption of fluoroquinolones, antibiotics, iron preparations and anticoagulants (oral).

When taking the medicine "Rutatsid" and other pharmaceuticals it is recommended to observe a 2-hour interval between their use.

Do not take this drug at the same time with juices, wine and other acid-containing beverages.

The period during which this medication retains all of the above properties is five years from the date indicated on the manufacturer's packaging.